Taken together, these results unveiled that different immune cells orchestrate adipose tissue inflammation during obesity development, and shed light on LTB4R1 as a potential therapeutic target to improve IR. The gene discussed is LTB4R; the disease is obesity due to melanocortin 4 receptor deficiency.